1. AI and immunology.
- Author
-
Germain RN, Van Allen EM, Trynka G, Tsang JS, Grün D, Kiemen AL, Shi Y, Pugh Bernard A, and Nolan GP
- Subjects
- Humans, Animals, Allergy and Immunology, Artificial Intelligence
- Abstract
AI is rapidly becoming part of many aspects of daily life, with an impact that reaches all fields of research. We asked investigators to share their thoughts on how AI is changing immunology research, what is necessary to move forward, the potential and the pitfalls, and what will remain unchanged as the field journeys into a new era., Competing Interests: Declaration of interests E.M.V.A. declares the following interests in advisory/consulting: Enara Bio, Manifold Bio, Monte Rosa, Novartis Institute for Biomedical Research, Serinus Bio; research support: Novartis, BMS, Sanofi, NextPoint; equity: Tango Therapeutics, Genome Medical, Genomic Life, Enara Bio, Manifold Bio, Microsoft, Monte Rosa, Riva Therapeutics, Serinus Bio, Syapse; patents: institutional patents filed on chromatin mutations and immunotherapy response, and methods for clinical interpretation; intermittent legal consulting on patents for Foaley & Hoag; editorial boards: Science Advances. J.S.T. serves on the SAB of CytoReason Inc., Immunoscape Inc., and as the co-CSO on the the Human Immunome Project (non-profit). D.G. serves on the scientific advisory board of Gordian Biotechnology., (Copyright © 2024. Published by Elsevier Inc.)
- Published
- 2024
- Full Text
- View/download PDF